Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:

NCT ID: NCT04045977 Completed - Clinical trials for Coronary Artery Disease

Virtual Therapy as a Method Supporting the Cardiac Rehabilitation

Start date: June 6, 2019
Phase: N/A
Study type: Interventional

This study evaluates the effectiveness of virtual reality (VR) therapy in the treatment of depression and anxiety symptoms in patients undergoing second stage of cardiac rehabilitation. Half of the study group will receive VR therapy (VR group) as an addition to cardiologically monitored physical training. The other half of the group (control group) will receive Schultz Autogenic Training as a standard supplement to cardiological training.

NCT ID: NCT04045067 Completed - Clinical trials for Cardiovascular Diseases

Low-voltage Areas Defragmentation in Sinus Rhythm for Radiofrequency Ablation of Persistent Atrial Fibrillation

SCAR-AF
Start date: September 25, 2019
Phase:
Study type: Observational

This is a study evaluating the value of defragmentation of sinus rhythmic low voltage areas in addition to isolation of pulmonary veins in the removal of recurrent atrial fibrillation. The invasive procedure will be performed according to the procedures chosen by the rhythmologist and will in no way be modified by the patient's enrollment in the study. Similarly, the frequency of consultations, date and nature of the additional examinations will be defined by the physician, with the purpose of monitoring the patient.

NCT ID: NCT04042896 Completed - Clinical trials for Cardiovascular Diseases

Effects of Exergame in Patients at High Cardiovascular Risk.

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

Background: Exergaming is thought to have a similar effect on cardiovascular (CV) responses as aerobic fitness activities. The aim of this study was to compare the cardiovascular effects of exergaming and traditional treadmill exercises in patients with high CV risk. Methods: Sixty-four patients with high CV risk were randomized among exergame (EG: n = 22), treadmill (TM: n = 22), and control (n=20) groups. The EG group was engaged in the running-based exergame using Exer Heart and the TM group walked or jogged on a treadmill. Cardiorespiratory fitness (CRF), brachial artery flow-mediated dilation (FMD), endothelial progenitor cell numbers (EPCs), epicardial fat thickness (EFT), metabolic parameters and anthropometric parameters were measured in patients before and 3 months after the training.

NCT ID: NCT04040777 Recruiting - Obesity Clinical Trials

Cardiometabolic Risk Factors Registry

CARFARE
Start date: June 2015
Phase:
Study type: Observational [Patient Registry]

CARFARE (CARDIOMETABOLIC RISK FACTORS REGISTRY) is a registry done in the context of a cardiovascular primary prevention program of the Cardiometabolic Unit Officia of the Cardiology Department of the Austral University Hospital. The structured and sequential evaluation include measurement of anthropometric parameters (body mass index, BMI), laboratory with metabolic profile, baseline electrocardiogram, blood pressure (BP) measurement, arterial stiffness, subclinical atherosclerosis screening in the carotid and ileo-femoral territories using echo-doppler, echocardiogram, and ergometry test.

NCT ID: NCT04040634 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)

Start date: August 8, 2019
Phase: N/A
Study type: Interventional

High blood pressure (BP) is a major public health concern, especially in low and middle income countries. High BP is a highly prevalent condition, and it is usually associated with diabetes mellitus. Both high BP and diabetes are risk factors for major cardiovascular events including cardiovascular death, acute myocardial infarction, stroke, unstable angina and heart failure. In addition, high BP is also related to cognitive decline. The OPTIMAL-DIABETES trial consists of a two-arm, multicenter, randomized clinical trial designed to test whether a lower systolic blood pressure (SBP) target will reduce the occurrence of major cardiovascular events in diabetic patients compared to the standard SBP target.

NCT ID: NCT04039854 Recruiting - Clinical trials for Cardiovascular Diseases

Comparison Between Propofol and Inhalational Anaesthetic Agents on Cardiovascular Outcomes Following Cardiac Surgery

COPIA
Start date: November 20, 2019
Phase: Phase 4
Study type: Interventional

The objective of this research proposal is to find out whether comparing the two different anaesthetic maintenance techniques (Propofol vs volatile anaesthetics) in adult patients undergoing heart surgery is practical for the anaesthetist treating the patients and whether it is feasible for the research team to recruit patients and follow them up after the operation.

NCT ID: NCT04037943 Completed - Clinical trials for Cardiovascular Diseases

NUTS for the Prevention of Cardiovascular Disease in Chinese Adults

NUTS
Start date: October 14, 2019
Phase: N/A
Study type: Interventional

This study evaluates the feasibility of walnuts supplementation among population of high CVD risks over a period of 6 months. 70 participants will be controls receiving non-edible gifts. 70 participants will be given 30 grams of walnuts everyday and 70 participants will be given 60 grams of walnuts a day.

NCT ID: NCT04037436 Completed - Stroke Clinical Trials

Functional Exercise and Nutrition Education Program for Older Adults

MoveStrong
Start date: September 24, 2019
Phase: N/A
Study type: Interventional

There is strong evidence that specific types of exercise can improve health and physical function in older adults. While community exercise classes exist, many older adults with chronic conditions may need guidance from credentialed exercise professionals to ensure sufficient dose and progression and to address fears or low exercise self-efficacy. Furthermore, low protein intake among older adults is common and initiating exercise when nutrition is inadequate may cause weight loss and limit gains in muscle strength. The primary goal is to determine the feasibility of implementing the MoveSTroNg program under real-world conditions, measured through referral and recruitment to the program and study retention and adherence rates.

NCT ID: NCT04036357 Recruiting - Clinical trials for Cardiovascular Diseases

Liver Damage and Cardiometabolic Disorders in NAFLD

PLINIO
Start date: November 2011
Phase:
Study type: Observational

Liver fibrosis is the most important prognostic factor in patients with non-alcoholic factor disease. Clinical and biological condition, as diabetes or mutation for PNPLA3, are well known factors associated with liver fibrosis onset and progression. However, little is known about biochemical factors predicting liver fibrosis evolution in large NAFLD populations.

NCT ID: NCT04034082 Completed - Clinical trials for Cardiovascular Disease

Intermittent Hypoxia Therapy in Cardiac Rehabilitation

Start date: February 12, 2019
Phase: N/A
Study type: Interventional

This is a randomized control pilot study to assess the effect of intermittent hypoxia therapy on functional capacity vs conventional care in old patients with functional impairment admitted to a Phase 2 in-hospital cardiac rehabilitation program.